Skip to main content

Carrie Anderson

Equibles does not estimate personal net worth.

Get an email with a short summary when CAMPBELL'S Co publishes a filing, an earnings call transcript or a press release.

Get CPB alerts

About Carrie Anderson

Carrie Anderson is recorded as CFO at CAMPBELL'S Co (CPB). Earlier roles on record: CFO at Integra Lifesciences Holdings Corp (IART) until February 2, 2023. Integra Lifesciences Holdings Corp reported in an 8-K filed January 25, 2023 that Carrie Anderson resigned as Chief Financial Officer, effective February 2, 2023. The proxy statement of CAMPBELL'S Co reports total compensation of $3,787,050 for Carrie Anderson in fiscal 2025, including a base salary of $803,677. Disclosed compensation is on record for 6 fiscal years. Carrie Anderson has spoken on 21 earnings calls across 2 companies, most recently for CAMPBELL'S Co on September 3, 2025. Those appearances were for Integra Lifesciences Holdings Corp (IART) and CAMPBELL'S Co (CPB). CAMPBELL'S Co is classified in the Packaged Foods industry within the Consumer Defensive sector. Other companies whose calls Carrie Anderson spoke on are classified in the Healthcare sector. Other leadership on record at CAMPBELL'S Co includes Mick J. Beekhuizen (CEO and Board Member), Carrie L. Anderson (CFO), Todd E. Cunfer (CFO) and 7 others.

“On January 25, 2023, Carrie Anderson, Chief Financial Officer of Integra LifeSciences Holdings Corporation (the “Company”), notified the Company of her decision to resign, effective as of February 2, 2023, to pursue another professional opportunity.”
Integra Lifesciences Holdings Corp Form 8-K, filed January 25, 2023 · Read the filing

Carrie Anderson on recent calls

“Turning to our Q4 results, as Mick said earlier, our fourth quarter performance was slightly ahead of our expectations. As a reminder, our Q4 and full-year results include the contribution of an additional week in fiscal 2025.”
CFO, CAMPBELL'S Co Q4 FY2025 Earnings Call ·
“As Mick said earlier, our third quarter performance exceeded our expectations. The overperformance in the quarter was primarily attributable to our meals and beverages division, which benefited from the timing of customer inventory orders.”
CFO, CAMPBELL'S Co Q3 FY2025 Earnings Call ·
“Our second quarter adjusted EPS was in line with our expectations, despite the dynamic operating environment Mick discussed earlier.”
CFO, CAMPBELL'S Co Q2 FY2025 Earnings Call ·
“Our first quarter results were generally in line with our expectations, with overperformance from Sovos Brands, and an earnings performance in line with expectations.”
CFO, CAMPBELL'S Co Q1 FY2025 Earnings Call ·
“I'll begin with an overview of our fourth quarter, including continued strong performance from the Sovos Brands acquisition. Fourth quarter reported net sales were up 11%, driven by the contribution from Sovos.”
CFO, CAMPBELL'S Co Q4 FY2024 Earnings Call ·

Affiliation history

Company network

Leadership on record at CAMPBELL'S Co

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 CAMPBELL'S Co (CPB) $803,677 $3,787,050
2024 CAMPBELL'S Co (CPB) $778,125 $3,855,472
2023 CAMPBELL'S Co (CPB) $361,823 $4,328,097
2023 Integra Lifesciences Holdings Corp (IART) $64,692 $67,280
2022 Integra Lifesciences Holdings Corp (IART) $565,404 $2,951,694
2021 Integra Lifesciences Holdings Corp (IART) $518,462 $2,636,663
2020 Integra Lifesciences Holdings Corp (IART) $466,346 $2,060,755

Recent activity

Show 10 earlier activities